CoVITEST: A Fast and Reliable Method to Monitor Anti-SARS-CoV-2 Specific T Cells From Whole Blood

dc.contributor.authorEgri, Natalia
dc.contributor.authorOlivé, Victoria
dc.contributor.authorHernández Rodríguez, José
dc.contributor.authorCastro, Pedro
dc.contributor.authorGuzman, Catherine de
dc.contributor.authorHeredia, Libertad
dc.contributor.authorCstellet Segura, Ana
dc.contributor.authorFernández, M. Dolores
dc.contributor.authorMoner, Noemí de
dc.contributor.authorTorradeflot, María
dc.contributor.authorBallús, Judit
dc.contributor.authorMartínez, Robert
dc.contributor.authorVázquez Portero, Mario
dc.contributor.authorVidal Costa, Marta
dc.contributor.authorDobaño, Carlota, 1969-
dc.contributor.authorMazza, Massimiliano
dc.contributor.authorMazzotti, Lucia
dc.contributor.authorPascal, Mariona
dc.contributor.authorJuan, Manel
dc.contributor.authorGonzález Navarro, Europa Azucena
dc.contributor.authorCalderón, Hugo
dc.date.accessioned2024-03-27T13:32:20Z
dc.date.available2024-03-27T13:32:20Z
dc.date.issued2023-07-06
dc.date.updated2023-07-06T14:21:05Z
dc.description.abstractCellular and humoral immune responses are essential for COVID-19 recovery and protection against SARS-CoV-2 reinfection. To date, the evaluation of SARS-CoV-2 immune protection has mainly focused on antibody detection, generally disregarding the cellular response, or placing it in a secondary position. This phenomenon may be explained by the complex nature of the assays needed to analyze cellular immunity compared with the technically simple and automated detection of antibodies. Nevertheless, a large body of evidence supports the relevance of the T cell's role in protection against SARS-CoV-2, especially in vulnerable individuals with a weakened immune system (such as the population over 65 and patients with immunodeficiencies). Here we propose to use CoVITEST (Covid19 anti-Viral Immunity based on T cells for Evaluation in a Simple Test), a fast, affordable and accessible in-house assay that, together with a diagnostic matrix, allows us to determine those patients who might be protected with SARS-CoV-2-reactive T cells. The method was established using healthy SARS-CoV-2-naïve donors pre- and post-vaccination (n=30), and further validated with convalescent COVID-19 donors (n=51) in a side-by-side comparison with the gold standard IFN-? ELISpot. We demonstrated that our CoVITEST presented reliable and comparable results to those obtained with the ELISpot technique in a considerably shorter time (less than 8 hours). In conclusion, we present a simple but reliable assay to determine cellular immunity against SARS-CoV-2 that can be used routinely during this pandemic to monitor the immune status in vulnerable patients and thereby adjust their therapeutic approaches. This method might indeed help to optimize and improve decision-making protocols for re-vaccination against SARS-CoV-2, at least for some population subsets.Copyright © 2022 Egri, Olivé, Hernández-Rodríguez, Castro, De Guzman, Heredia, Segura, Fernandez, de Moner, Torradeflot, Ballús, Martinez, Vazquez, Costa, Dobaño, Mazza, Mazzotti, Pascal, Juan, González-Navarro and Calderón.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina9325444
dc.identifier.issn1664-3224
dc.identifier.pmid35865538
dc.identifier.urihttps://hdl.handle.net/2445/209233
dc.language.isoeng
dc.publisherFrontiers
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fimmu.2022.848586
dc.relation.ispartofFrontiers In Immunology, 2022, vol. 13
dc.relation.urihttps://doi.org/10.3389/fimmu.2022.848586
dc.rightscc by (c) Egri, Natalia et al, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationCOVID-19
dc.subject.classificationDiagnòstic
dc.subject.otherCOVID-19
dc.subject.otherDiagnosis
dc.titleCoVITEST: A Fast and Reliable Method to Monitor Anti-SARS-CoV-2 Specific T Cells From Whole Blood
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
CoVITEST A Fast and Reliable Method to Monitor Anti-SARS-CoV-2_FrontiersInImmunology.pdf
Mida:
2.14 MB
Format:
Adobe Portable Document Format